We hope to see you again soon!

You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.

UK-NOTPR-1010 | April 2022



About Us

Lundbeck is a Global Pharmaceutical Company Specialising in Brain Diseases

We are tirelessly dedicated to restoring brain health, so every person can be their best. To fulfill this purpose, Lundbeck engages in the research, development, manufacturing, and commercialisation of pharmaceuticals across the world. For more than 70 years, Lundbeck has been at the forefront of neuroscience research.

Our Commitment

Beyond developing new and improved medical therapies, we commit to empowering patients, challenging the status quo, helping families and strengthening communities.

This is Lundbeck

One of the only pharmaceutical companies in the world focusing exclusively on brain diseases and recognised for having helped hundreds of millions of people with brain diseases.

Our Strategy

Lundbeck’s strategy, Expand and Invest to Grow, was announced in 2019 with the ambition to invigorate future growth.

At Lundbeck, we have a two-tier management structure consisting of our Board of Directors and Executive Management.

Corporate Governance

Our governance framework consists of rules and principles that support sustainable financial performance and long-term value creation for all our stakeholders.

Our Charity Work

Lundbeck UK believes improving the quality of life for patients is best achieved through investment in knowledge, research, education and a holistic attitude to patient care.

UK-NOTPR-0520 | April 2022